Uri Sagman

1.1k total citations
19 papers, 905 citations indexed

About

Uri Sagman is a scholar working on Epidemiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Uri Sagman has authored 19 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Uri Sagman's work include Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (10 papers) and Peptidase Inhibition and Analysis (4 papers). Uri Sagman is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (10 papers) and Peptidase Inhibition and Analysis (4 papers). Uri Sagman collaborates with scholars based in Canada, United States and India. Uri Sagman's co-authors include Monica De Metrio, J. Fernandes, James W. Dennis, Manon Auger, William K. Evans, J L Yeoh, David G. Payne, Ellen Maki, Frances A. Shepherd and Riad Haddad and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Uri Sagman

19 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uri Sagman Canada 11 461 381 355 231 177 19 905
Hitoyasu Futami Japan 16 420 0.9× 330 0.9× 246 0.7× 115 0.5× 69 0.4× 41 869
Nyam Kamsu-Kom France 10 615 1.3× 662 1.7× 113 0.3× 117 0.5× 101 0.6× 12 1.0k
Motokazu Suyama Japan 12 487 1.1× 433 1.1× 95 0.3× 258 1.1× 70 0.4× 31 954
Theresa A. Mays United States 10 477 1.0× 773 2.0× 54 0.2× 218 0.9× 126 0.7× 15 1.2k
Tiantao Kuang China 19 718 1.6× 566 1.5× 168 0.5× 155 0.7× 238 1.3× 58 1.3k
M. Koukourakis Greece 12 227 0.5× 284 0.7× 75 0.2× 125 0.5× 65 0.4× 28 563
Shinichiro Ryuge Japan 18 347 0.8× 417 1.1× 97 0.3× 239 1.0× 108 0.6× 36 738
Fabrice Branle Switzerland 15 951 2.1× 578 1.5× 219 0.6× 796 3.4× 46 0.3× 36 1.5k
Paola Claudia Sacco Italy 18 505 1.1× 340 0.9× 74 0.2× 438 1.9× 89 0.5× 42 889
Carla Kurkjian United States 17 302 0.7× 481 1.3× 58 0.2× 157 0.7× 60 0.3× 41 830

Countries citing papers authored by Uri Sagman

Since Specialization
Citations

This map shows the geographic impact of Uri Sagman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Sagman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Sagman more than expected).

Fields of papers citing papers by Uri Sagman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Sagman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Sagman. The network helps show where Uri Sagman may publish in the future.

Co-authorship network of co-authors of Uri Sagman

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Sagman. A scholar is included among the top collaborators of Uri Sagman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Sagman. Uri Sagman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Feld, R. & Uri Sagman. (1995). Prognostic factors in small cell lung cancer. Seminars in Radiation Oncology. 5(1). 27–32. 7 indexed citations
2.
Shepherd, Frances A., Robert J. Ginsberg, Riad Haddad, et al.. (1993). Importance of clinical staging in limited small-cell lung cancer: a valuable system to separate prognostic subgroups. The University of Toronto Lung Oncology Group.. Journal of Clinical Oncology. 11(8). 1592–1597. 60 indexed citations
3.
Sagman, Uri, Michael Lishner, Ellen Maki, et al.. (1992). Second primary malignancies following diagnosis of small-cell lung cancer.. Journal of Clinical Oncology. 10(10). 1525–1533. 61 indexed citations
4.
Sagman, Uri, Ronald Feld, William K. Evans, et al.. (1991). The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.. Journal of Clinical Oncology. 9(6). 954–961. 75 indexed citations
5.
Sagman, Uri, Ellen Maki, William K. Evans, et al.. (1991). Small-cell carcinoma of the lung: derivation of a prognostic staging system.. Journal of Clinical Oncology. 9(9). 1639–1649. 119 indexed citations
6.
Fernandes, J., Uri Sagman, Manon Auger, Monica De Metrio, & James W. Dennis. (1991). Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia.. PubMed. 51(2). 718–23. 318 indexed citations
7.
Sagman, Uri, J. Brendan M. Mullen, Kalman Kovacs, et al.. (1990). Identification of somatostatin receptors in human small cell lung carcinoma. Cancer. 66(10). 2129–2133. 37 indexed citations
8.
Moran, Antoinette, L. Sylvia, Kálmán Kovács, et al.. (1990). Gigantism Due to Pituitary Mammosomatotroph Hyperplasia. New England Journal of Medicine. 323(5). 322–327. 51 indexed citations
9.
Lishner, Michael, Ronald Feld, David G. Payne, et al.. (1990). Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience.. Journal of Clinical Oncology. 8(2). 215–221. 73 indexed citations
11.
Biran, Haim, R. Feld, Uri Sagman, et al.. (1989). Carcinoembryonic Antigen, Arginine Vasopressin and Calcitonin as Markers of Early Small-Cell Lung Cancer Relapse. Tumor Biology. 10(5). 258–267. 8 indexed citations
12.
Champagne, Éric, et al.. (1989). The T-cell receptor delta chain locus is disrupted in the T-ALL associated t(11;14)(p13;q11) translocation. Blood. 73(6). 1672–1676. 24 indexed citations
13.
Sagman, Uri. (1989). Small cell lung cancer complications: late toxicity. Lung Cancer. 5(4-6). 311–318. 1 indexed citations
14.
Champagne, Éric, et al.. (1989). The T-cell receptor delta chain locus is disrupted in the T-ALL associated t(11;14)(p13;q11) translocation. Blood. 73(6). 1672–1676. 2 indexed citations
15.
Bunn, Paul A., Michael Cullen, Masahiro Fukuoka, et al.. (1989). Chemotherapy in small cell lung cancer: a consensus report. Lung Cancer. 5(4-6). 127–134. 30 indexed citations
16.
Sagman, Uri, et al.. (1988). Évaluation de classifications par le critère d'Akaike et la validation croisée. French digital mathematics library (Numdam). 36(3). 33–50. 1 indexed citations
17.
Feld, Ronald, Gerrit DeBoer, & Uri Sagman. (1988). Prognostic factors for small cell carcinoma of the lung. European Journal of Cancer and Clinical Oncology. 24(3). 353–355. 10 indexed citations
18.
Champagne, Éric, Uri Sagman, Andrea Biondi, et al.. (1988). Structure and rearrangement of the T cell receptor J alpha locus in T cells and leukemic T cell lines. European Journal of Immunology. 18(7). 1033–1038. 8 indexed citations
19.
Champagne, Éric, et al.. (1988). The isolation of the human delta chain gene and its expression in normal T cells and T cell leukemias.. PubMed. 2(11). 717–21. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026